If you are having difficulties listening to this Podcast, try to play this episode in Spotify
The big news this week has been the risk of cerebral venous sinus thrombosis post-AZ vaccine and it's been giving us all a headache, but this has overshadowed further new data confirming benefit of inhaled corticosteroids for acute mild covid and guidance that we can offer this to older patients on a case-by-case basis.
In the latest Hot Topics podcast Neal Tucker discusses the facts, figures, management and ethics of post-AZ vaccine thrombosis, reviews the Principle trial showing we now have a viable treatment for mild covid; and data on the rate of multi-organ dysfunction and death at 4 months post-hospital discharge for covid.
References
MHRA data on AZ vaccine and thrombosis risk
CDC Data on Johnson&Johnson vaccine and thrombosis risk
CDC Data on Transmission Reduction